Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Revenio Group Corp (REG1V) EUR0.30

Sell:€19.28 Buy:€19.30 Change: No change
Market closed |  Prices as at close on 13 September 2019 | Switch to live prices |
Sell:€19.28
Buy:€19.30
Change: No change
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
Market closed |  Prices as at close on 13 September 2019 | Switch to live prices |
Sell:€19.28
Buy:€19.30
Change: No change
Market closed |  Prices as at close on 13 September 2019 | Switch to live prices |
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Revenio Group Oyj, formerly Done Solutions Oyj, is a Finland-based company primarily engaged in the health technology segment. The Company’s activities are divided into two business areas: Revenio Health Tech, which is responsible for the design, manufacture and sale of tonometers and bone density measurement devices; as well as Revenio Technology and Services, which provides contact center services for material handling systems. It distributes products in a range of countries, including the United States, Canada, Australia, Japan and India. Furthermore, the Company is a parent of Done Medical Oy, Kauhajoen Sisalogistiikka Oy, Icare Finland Oy, Oscare Medical Oy and Midas Touch Oy, among others.

Contact details

Address:
Ayritie 22
VANTAA
01510
Finland
Telephone:
+358 (2) 052525
Website:
https://www.reveniogroup.fi/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
REG1V
ISIN:
FI0009010912
Market cap:
€509.74 million
Shares in issue:
26.31 million
Sector:
Health Care Equipment
Exchange:
Helsinki Stock Exchange
Country:
Finland
Currency:
Euro
Indices:
n/a

Key personnel

  • Pekka Ronka
    Independent Chairman of the Board
  • Mikko Moilanen
    Chief Executive Officer, Member of the Management Team
  • Robin Pulkkinen
    Chief Financial Officer, Member of the Management Team
  • John Floyd
    Chief Executive Officer of Icare USA
  • Ari Kukkonen
    Senior Advisor
  • Tiina Olkkonen
    External Communications Specialist, Member of the Management Team, Secretary
  • Ari Isomaki
    Icare Finland Ltd Operations Director, Member of the Management Team,
  • Tomi Karvo
    Icare Finland's Sales and Marketing Director, Member of the Management Team
  • Mika Salkola
    Revenio Research Oy's R&D Director, Member of the Group Management Team
  • Heli Valtanen
    Icare Finland Ltd's QA Manager, Member of the Group Management Team

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.
Deal now Deal for just £11.95 per trade in a ISA, Lifetime ISA, SIPP or Fund & Share Account

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.